These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25393609)

  • 1. Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.
    Sokolow S; Henkins KM; Bilousova T; Gonzalez B; Vinters HV; Miller CA; Cornwell L; Poon WW; Gylys KH
    J Neurochem; 2015 May; 133(3):368-79. PubMed ID: 25393609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal tau with seeding activity is released from Alzheimer's disease synapses, and seeding potential is associated with amyloid beta.
    Miyoshi E; Bilousova T; Melnik M; Fakhrutdinov D; Poon WW; Vinters HV; Miller CA; Corrada M; Kawas C; Bohannan R; Caraway C; Elias C; Maina KN; Campagna JJ; John V; Gylys KH
    Lab Invest; 2021 Dec; 101(12):1605-1617. PubMed ID: 34462532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive p-tau pathology and SDS-stable p-tau oligomers in Alzheimer's cortical synapses.
    Henkins KM; Sokolow S; Miller CA; Vinters HV; Poon WW; Cornwell LB; Saing T; Gylys KH
    Brain Pathol; 2012 Nov; 22(6):826-33. PubMed ID: 22486774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of synaptic terminals from Alzheimer's disease cortex.
    Sokolow S; Henkins KM; Williams IA; Vinters HV; Schmid I; Cole GM; Gylys KH
    Cytometry A; 2012 Mar; 81(3):248-54. PubMed ID: 22213704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system.
    Tai HC; Serrano-Pozo A; Hashimoto T; Frosch MP; Spires-Jones TL; Hyman BT
    Am J Pathol; 2012 Oct; 181(4):1426-35. PubMed ID: 22867711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases.
    Bilousova T; Miller CA; Poon WW; Vinters HV; Corrada M; Kawas C; Hayden EY; Teplow DB; Glabe C; Albay R; Cole GM; Teng E; Gylys KH
    Am J Pathol; 2016 Jan; 186(1):185-98. PubMed ID: 26718979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence.
    Gylys KH; Fein JA; Yang F; Wiley DJ; Miller CA; Cole GM
    Am J Pathol; 2004 Nov; 165(5):1809-17. PubMed ID: 15509549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.
    Sokolow S; Luu SH; Nandy K; Miller CA; Vinters HV; Poon WW; Gylys KH
    Neurobiol Dis; 2012 Jan; 45(1):381-7. PubMed ID: 21914482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers.
    Singh A; Allen D; Fracassi A; Tumurbaatar B; Natarajan C; Scaduto P; Woltjer R; Kayed R; Limon A; Krishnan B; Taglialatela G
    J Alzheimers Dis; 2020; 78(4):1661-1678. PubMed ID: 33185603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes.
    Fein JA; Sokolow S; Miller CA; Vinters HV; Yang F; Cole GM; Gylys KH
    Am J Pathol; 2008 Jun; 172(6):1683-92. PubMed ID: 18467692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic oligomeric tau in Alzheimer's disease - A potential culprit in the spread of tau pathology through the brain.
    Colom-Cadena M; Davies C; Sirisi S; Lee JE; Simzer EM; Tzioras M; Querol-Vilaseca M; Sánchez-Aced É; Chang YY; Holt K; McGeachan RI; Rose J; Tulloch J; Wilkins L; Smith C; Andrian T; Belbin O; Pujals S; Horrocks MH; Lleó A; Spires-Jones TL
    Neuron; 2023 Jul; 111(14):2170-2183.e6. PubMed ID: 37192625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
    Willén K; Sroka A; Takahashi RH; Gouras GK
    J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.
    Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH
    Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
    Muntané G; Dalfó E; Martinez A; Ferrer I
    Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease.
    Pickett EK; Rose J; McCrory C; McKenzie CA; King D; Smith C; Gillingwater TH; Henstridge CM; Spires-Jones TL
    Acta Neuropathol; 2018 Nov; 136(5):747-757. PubMed ID: 30191401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
    Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P
    Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aβ/tau oligomer interplay at human synapses supports shifting therapeutic targets for Alzheimer's disease.
    Marcatti M; Fracassi A; Montalbano M; Natarajan C; Krishnan B; Kayed R; Taglialatela G
    Cell Mol Life Sci; 2022 Apr; 79(4):222. PubMed ID: 35377002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy.
    Borreca A; Latina V; Corsetti V; Middei S; Piccinin S; Della Valle F; Bussani R; Ammassari-Teule M; Nisticò R; Calissano P; Amadoro G
    Mol Neurobiol; 2018 Oct; 55(10):8124-8153. PubMed ID: 29508283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Amyloid Induces Pathology-Related Patterns of Tau Hyperphosphorylation at Synaptic Terminals.
    Wu HY; Kuo PC; Wang YT; Lin HT; Roe AD; Wang BY; Han CL; Hyman BT; Chen YJ; Tai HC
    J Neuropathol Exp Neurol; 2018 Sep; 77(9):814-826. PubMed ID: 30016458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.